Kiyatec Inc.

Kiyatec Inc.

Biotechnology Research

Greenville, SC 2,709 followers

Changing the future of cancer care by accurately predicting patient response to therapies before treatment begins

About us

Kiyatec is disrupting cancer care by accurately predicting patient–specific response and non–response before treatment begins. We utilize the patient’s own living tumor cells to create functional 3D models to test a battery of cancer therapies in our CLIA-certified and research laboratories. Our goal is to enable physicians to isolate only the effective treatments for their patients as quickly as possible - making true personalized medicine a reality. Our approach has been validated through engagements with leading cancer hospitals, multiple top 10 pharmaceutical companies and the NCI. We are conducting robust clinical trials to fully demonstrate the power of our approach and earn widespread adoption for a broad portfolio of products predicting response to today’s and tomorrow’s therapies. www.kiyatec.com

Industry
Biotechnology Research
Company size
11-50 employees
Headquarters
Greenville, SC
Type
Privately Held
Founded
2010
Specialties
3D Cell Culture Technologies, High Content Drug Discovery, Personalized Cancer Diagnostics, Contract Research Organization (CRO), Preclinical Drug Development, Drug Response Profiling, Oncology Drug Response Profiling, Oncology Drug Screening, and Immune Oncology

Locations

Employees at Kiyatec Inc.

Updates

Similar pages

Browse jobs